Altered B cell functioning in diabetes mellitus patients leads to increased inflammation via the following two mechanisms: increased pro-inflammatory IL-8 production and a lack of anti-inflammatory/protective IL-10 production [46]. The gene discussed is CXCL8; the disease is diabetes mellitus.